Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Bantel

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Cell Death Discovery|August 2, 2023
Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosisKatharina Staufer, Heidemarie Huber, Jasmin Zessner-Spitzenberg, et al.
Frontiers in Immunology|July 26, 2021
The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic InflammationFabian Richter, Sarah K Williams, Katharina John, et al.
Annals of Hepatology|August 15, 2024
Evaluation of four chatbots in autoimmune liver disease: A comparative analysisJimmy Daza, Lucas Soares Bezerra, Laura Santamaría, et al.
Zeitschrift Fur Gastroenterologie|May 20, 2026
Marcial Sebode, Heike Bantel, Ulrich Baumann, et al.
Oncoimmunology|February 25, 2021
Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancerNataliia Petriv, Lavinia Neubert, Myroslava Vatashchuk, et al.
Zeitschrift Fur Gastroenterologie|July 8, 2024
Elke Roeb, Ali Canbay, Heike Bantel, et al.
Gut|November 27, 2019
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cellsZhen Dai, Guangqi Song, Asha Balakrishnan, et al.
Journal of Viral Hepatitis|November 13, 2020
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reductionOlympia E Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, et al.
Oncotarget|May 21, 2017
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysisMirko Dengler, Katharina Staufer, Heidemarie Huber, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and diseaseHong Jiang, Eric Schiffer, Zhangfa Song, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Cell Death Discovery|August 2, 2023
Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosisKatharina Staufer, Heidemarie Huber, Jasmin Zessner-Spitzenberg, et al.
Frontiers in Immunology|July 26, 2021
The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic InflammationFabian Richter, Sarah K Williams, Katharina John, et al.
Annals of Hepatology|August 15, 2024
Evaluation of four chatbots in autoimmune liver disease: A comparative analysisJimmy Daza, Lucas Soares Bezerra, Laura Santamaría, et al.
Zeitschrift Fur Gastroenterologie|May 20, 2026
Marcial Sebode, Heike Bantel, Ulrich Baumann, et al.
Oncoimmunology|February 25, 2021
Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancerNataliia Petriv, Lavinia Neubert, Myroslava Vatashchuk, et al.
Zeitschrift Fur Gastroenterologie|July 8, 2024
Elke Roeb, Ali Canbay, Heike Bantel, et al.
Gut|November 27, 2019
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cellsZhen Dai, Guangqi Song, Asha Balakrishnan, et al.
Journal of Viral Hepatitis|November 13, 2020
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reductionOlympia E Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, et al.
Oncotarget|May 21, 2017
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysisMirko Dengler, Katharina Staufer, Heidemarie Huber, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and diseaseHong Jiang, Eric Schiffer, Zhangfa Song, et al.
Pageof 11